Global Edition news

By Dave Muoio 03:27 pm July 15, 2019
Patients who enrolled in a physical activity trial enjoyed a long-term benefit of fewer cardiovascular events and bone fractures up to four years after the intervention was completed. According to a new review of these patients’ routine primary care records published in PLoS Medicine, the data support further rollout of pedometer-based walking programs among older adults, even if the intervention...
By Dave Muoio 02:18 pm July 10, 2019
Virtual until proven fraudulent. A New York anesthesiologist has been indicted for her role in a scheme to submit fraudulent telemedicine claims to Medicare, Medicare Part D plans as we. According to the indictment, Dr. Anna Steiner and other providers purported to practice telemedicine in exchange for kickbacks starting in 2015. This resulted in more than $7 million in Medicare claims on behalf...
By Nathan Eddy 11:36 am July 9, 2019
Cloud-based computing could offer major benefits to pharmaceutical companies in the area of drug development as they grapple with rising costs and avalanches of data that need to be collected, analyzed and shared. In particular, the technology could help streamline operations and develop business cases as to whether a drug is likely to be needed — or financially viable. “If you’ve got big pots of...
By Laura Lovett 03:31 pm July 8, 2019
Pharmaceutical company UCB and DEARhealth, a disease management software company, are joining forces on a new initiative aimed at predicting health outcomes for patients with epilepsy. The pair will use DEARhealth’s platform, which integrates artificial intelligence with EHRs. “This technology will ensure that specific subpopulations within epilepsy will all receive the specific care needed for...
By Dave Muoio 02:48 pm July 5, 2019
The first quarter of 2019 may have been a tad slow, but the past three months have shown that investors are still ready to pony up for digital health companies of every shape and size. The $2.45 billion in fundraising that MobiHealthNews covered in April, May and June isn’t quite the highest quarterly total (that distinction goes to Q3 of 2018), but it came from an impressive 81 separate funding...
By Laura Lovett 01:50 pm July 3, 2019
Diving deeper into digital, this quarter the pharma giants have continued to implement new tools to enhance clinical trials, support medication management with technology and partner in developing digital therapeutics.  Onc, a foreign entity to this established industry, pharma executives are now becoming better versed in working with digital health companies and sharing the lessons they've...
By Laura Lovett 04:15 pm July 1, 2019
It would be hard to discuss healthcare trends without talking about what this means for the behemoth pharma industry. Recently, new kid on the block digital health has started to turn heads in across this well-established sector with its potential for improving R&D, tracking real-world evidence and even creating a new type of medicine with digital therapeutics.  While digital promises the...
By Laura Lovett 03:16 pm July 1, 2019
In spite of predictions that digital health funding would slow in 2019, the industry is on track for yet another record-shattering year of funding, according to the latest Rock Health report. Now at the midway point, 2019 has seen a total of $4.2 billion dollars of digital health investment dollars by the agency's count.  “If this pace holds steady, the sector is on track for an $8.4 billion year...

Editor's Pick